Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.8
0 %
$ 10.4 M
Market Cap
0.94
P/E
EGRX - COST OF REVENUE
Cost of Revenue EGRX - Eagle Pharmaceuticals, Inc.
94.9 M
LAST VALUE
44.50%
2 YEAR CAGR
10.67%
5 YEAR CAGR
40.51%
10 YEAR CAGR